These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 21993403)

  • 1. Node-negative T1-T2 anal cancer: radiotherapy alone or concomitant chemoradiotherapy?
    Zilli T; Schick U; Ozsahin M; Gervaz P; Roth AD; Allal AS
    Radiother Oncol; 2012 Jan; 102(1):62-7. PubMed ID: 21993403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elective inguinal node irradiation in early-stage T2N0 anal cancer: prognostic impact on locoregional control.
    Zilli T; Betz M; Bieri S; Ris F; Roche B; Roth AD; Allal AS
    Int J Radiat Oncol Biol Phys; 2013 Sep; 87(1):60-6. PubMed ID: 23608237
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction chemotherapy improved outcomes of patients with resectable esophageal cancer who received chemoradiotherapy followed by surgery.
    Jin J; Liao Z; Zhang Z; Ajani J; Swisher S; Chang JY; Jeter M; Guerrero T; Stevens CW; Vaporciyan A; Putnam J; Walsh G; Smythe R; Roth J; Yao J; Allen P; Cox JD; Komaki R
    Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):427-36. PubMed ID: 15380576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Squamous cell carcinoma of the anal margin: the university of Florida experience.
    Balamucki CJ; Zlotecki RA; Rout WR; Newlin HE; Morris CG; Kirwan JM; George TJ; Mendenhall WM
    Am J Clin Oncol; 2011 Aug; 34(4):406-10. PubMed ID: 20881476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemoradiotherapy of anal carcinoma: survival and recurrence in an unselected national cohort.
    Bentzen AG; Guren MG; Wanderås EH; Frykholm G; Tveit KM; Wilsgaard T; Dahl O; Balteskard L
    Int J Radiat Oncol Biol Phys; 2012 Jun; 83(2):e173-80. PubMed ID: 22436791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor site predicts outcome after radiochemotherapy in squamous-cell carcinoma of the anal region: long-term results of 101 patients.
    Grabenbauer GG; Kessler H; Matzel KE; Sauer R; Hohenberger W; Schneider IH
    Dis Colon Rectum; 2005 Sep; 48(9):1742-51. PubMed ID: 15991058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Epidermoid carcinomas of anal canal treated with radiation therapy and concomitant chemotherapy (5-fluorouracil and cisplatin)].
    Deniaud-Alexandre E; Touboul E; Tiret E; Sezeur A; Hannoun L; Houry S; Huguet F; Pène F; Parc R; Schlienger M
    Cancer Radiother; 2006 Dec; 10(8):572-82. PubMed ID: 17110148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiotherapy for epidermoid carcinoma of the anus: thirty years' experience.
    Myerson RJ; Outlaw ED; Chang A; Birnbaum EH; Fleshman JW; Grigsby PW; Kodner IJ; Malayapa RS; Mutch MG; Parikh P; Picus J; Tan BR
    Int J Radiat Oncol Biol Phys; 2009 Oct; 75(2):428-35. PubMed ID: 19251377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prognosis of epidermoid anal carcinoma regression after conservative treatment].
    Vorob'ëv GI; Odariuk TS; Orlova LP; Nechushkin MI; Rybakov EG
    Vopr Onkol; 2004; 50(6):663-7. PubMed ID: 15755059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidermal growth factor receptor expression as prognostic marker in patients with anal carcinoma treated with concurrent chemoradiation therapy.
    Fraunholz I; Rödel F; Kohler D; Diallo-Georgiopoulou M; Distel L; Falk S; Rödel C
    Int J Radiat Oncol Biol Phys; 2013 Aug; 86(5):901-7. PubMed ID: 23755922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Twenty-five-year experience with radical chemoradiation for anal cancer.
    Tomaszewski JM; Link E; Leong T; Heriot A; Vazquez M; Chander S; Chu J; Foo M; Lee MT; Lynch CA; Mackay J; Michael M; Tran P; Ngan SY
    Int J Radiat Oncol Biol Phys; 2012 Jun; 83(2):552-8. PubMed ID: 22019078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conformal therapy improves the therapeutic index of patients with anal canal cancer treated with combined chemotherapy and external beam radiotherapy.
    Vuong T; Kopek N; Ducruet T; Portelance L; Faria S; Bahoric B; Devic S
    Int J Radiat Oncol Biol Phys; 2007 Apr; 67(5):1394-400. PubMed ID: 17276620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Concurrent chemoradiotherapy with 5-fluorouracil and mitomycin C for invasive anal carcinoma in human immunodeficiency virus-positive patients receiving highly active antiretroviral therapy.
    Fraunholz I; Weiss C; Eberlein K; Haberl A; Rödel C
    Int J Radiat Oncol Biol Phys; 2010 Apr; 76(5):1425-32. PubMed ID: 19744801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The therapeutic results and early and late toxicities of the treatment of anal canal carcinoma by radiotherapy or chemoradiotherapy].
    Sommer K; Brockmann WP; Wiegel T; Krüll A; Hübener KH; Birk S
    Strahlenther Onkol; 1991 Aug; 167(8):445-51. PubMed ID: 1909466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cisplatin-based combined modality therapy for anal carcinoma: a wider therapeutic index.
    Hung A; Crane C; Delclos M; Ballo M; Ajani J; Lin E; Feig B; Skibber J; Janjan N
    Cancer; 2003 Mar; 97(5):1195-202. PubMed ID: 12599225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of radiotherapy, chemotherapy and surgery in multimodal treatment of locally advanced esophageal cancer.
    Berger B; Stahlberg K; Lemminger A; Bleif M; Belka C; Bamberg M
    Oncology; 2011; 81(5-6):387-94. PubMed ID: 22269965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes of chemoradiotherapy with 5-Fluorouracil and mitomycin C for anal cancer in immunocompetent versus immunodeficient patients.
    Seo Y; Kinsella MT; Reynolds HL; Chipman G; Remick SC; Kinsella TJ
    Int J Radiat Oncol Biol Phys; 2009 Sep; 75(1):143-9. PubMed ID: 19203845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involved-field, low-dose chemoradiotherapy for early-stage anal carcinoma.
    Hatfield P; Cooper R; Sebag-Montefiore D
    Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):419-24. PubMed ID: 17919842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Esophagectomy after concurrent chemoradiotherapy improves locoregional control in clinical stage II or III esophageal cancer patients.
    Liao Z; Zhang Z; Jin J; Ajani JA; Swisher SG; Stevens CW; Ho L; Smythe R; Vaporciyan AA; Putnam JB; Walsh GL; Roth JA; Yao JC; Allen PK; Cox JD; Komaki R
    Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1484-93. PubMed ID: 15590179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiochemotherapy in the conservative treatment of anal canal carcinoma: retrospective analysis of results and radiation dose effectiveness.
    Ferrigno R; Nakamura RA; Dos Santos Novaes PE; Pellizzon AC; Maia MA; Fogarolli RC; Salvajoli JV; Filho WJ; Lopes A
    Int J Radiat Oncol Biol Phys; 2005 Mar; 61(4):1136-42. PubMed ID: 15752894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.